Ying Maggie Chen to Speak at Yale Symposium

Ying-Maggie-Chen-MD

Ying Maggie Chen, MD, PhD, Associate Professor of Medicine in the Division of Nephrology at Washington University in St. Louis, will present at the 2021 George M. O’Brien Kidney Center at Yale Annual Symposium.  The virtual event will be held Friday, May 7, 2021.  Advances in Kidney Research is the theme of this year’s symposium. […]

Dr. Maggie Chen Receives $1.8M Department of Defense Grant to Develop Treatment for FSGS

Congratulations to Ying “Maggie” Chen, MD, PhD, Assistant Professor of Medicine, Nephrology, who was awarded a $1.8 million grant (total cost) from the U.S. Department of Defense for her study “Development of Novel Podocyte Endoplasmic Reticulum (ER) Calcium Stabilizers to Treat Focal Segmental Glomerulosclerosis (FSGS).” FSGS is the most common primary glomerulopathy leading to renal […]

Patent Issued for Urinary Biomarkers for ER Stress-Mediated Kidney Disease

A U.S. patent was issued on 12/18/2018 to Division of Nephrology faculty member Ying (Maggie) Chen, MD, PhD, and co-inventor Yeawon Kim for their discovery of noninvasive biomarkers that have the potential to help diagnose certain human kidney diseases in their earliest stages of development. The patent is based on their research published in JCI […]

Broad Clinical Applications for CRELD2 as an ER Stress Biomarker

Thanks to a new study headed by Ying Maggie Chen, MD, PhD, it may soon be possible to diagnose certain human kidney diseases in their earliest stages of development using a noninvasive biomarker of endoplasmic reticulum (ER) stress. The study, Elevated Urinary CRELD2 is Associated with Endoplasmic Reticulum Stress-mediated Kidney Disease, was published online in […]